The Role of Fibroblast Growth Factor-Receptor Pathway Aberrations in Pediatric Diseases

References (53)

1. 1 An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis [DOI]
2. 2 Mechanisms underlying differential responses to FGF signaling [DOI]
3. 3 Achondroplasia [DOI]
4. 4 Exploring mechanisms of FGF signalling through the lens of structural biology [DOI]
5. 5 Molecular Pathways: Fibroblast Growth Factor Signaling: A New Therapeutic Opportunity in Cancer [DOI]
6. 6 Fibroblast Growth Factor (FGF) and FGF Receptor-Mediated Autocrine Signaling in Non-Small-Cell Lung Cancer Cells [DOI]
7. 7 Inhibition of FGF‐FGFR and VEGF‐VEGFR signalling in cancer treatment [DOI]
8. 8 Mechanisms of FGFR-mediated carcinogenesis [DOI]
9. 9 Fibroblast Growth Factor Receptors (FGFRs) and Noncanonical Partners in Cancer Signaling [DOI]
10. 10 Targeting the fibroblast growth factor receptor family in cancer [DOI]
11. 11 FGF Receptor Inhibitors: Role in Cancer Therapy [DOI]
12. 12 The role of fibroblast growth factor 8 in cartilage development and disease [DOI]
13. 13 Fibroblast growth factor 15/19 expression, regulation, and function: An overview [DOI]
14. 14 Fibroblast Growth Factors as Multifunctional Signaling Factors [DOI]
15. 15 FGF signaling regulates mesenchymal differentiation and skeletal patterning along the limb bud proximodistal axis [DOI]
16. 16 Activation of the ERK1/2 and p38 Mitogen-activated Protein Kinase Pathways Mediates Fibroblast Growth Factor-induced Growth Arrest of Chondrocytes [DOI]
17. 17 FGF/FGFR signaling in bone formation: Progress and perspectives [DOI]
18. 18 Dysregulated FGF signalling in neoplastic disorders [DOI]
19. 19 Signaling by FGF Receptor 2, Not FGF Receptor 1, Regulates Myelin Thickness through Activation of ERK1/2–MAPK, Which Promotes mTORC1 Activity in an Akt-Independent Manner [DOI]
20. 20 The ins and outs of fibroblast growth factor receptor signalling [DOI]
21. 21 FGFR3 targeting strategies for achondroplasia [DOI]
22. 22 Adding to the Mix: Fibroblast Growth Factor and Platelet-Derived Growth Factor Receptor Pathways as Targets in Non – small Cell Lung Cancer [DOI]
23. 23 Extrarenal effects of FGF23 [DOI]
24. 24 Fibroblast growth factor receptor signaling as therapeutic targets in gastric cancer [DOI]
25. 25 Fibroblast Growth Factor Receptor Inhibitors [DOI]
26. 26 The Emerging Role of the FGF/FGFR Pathway in Gastrointestinal Stromal Tumor [DOI]
27. 27 New developments in the management of achondroplasia [DOI]
28. 28 Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling [DOI]
29. 29 Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications [DOI]
30. 30 Targeting the FGF/FGFR axis and its co-alteration allies [DOI]
31. 31 Fibroblast growth factor (FGF), FGF receptor (FGFR), and cyclin D1 (CCND1) DNA methylation in head and neck squamous cell carcinomas is associated with transcriptional activity, gene amplification, human papillomavirus (HPV) status, and sensitivity to tyrosine kinase inhibitors [DOI]
32. 32 Roles of FGFR in oral carcinogenesis [DOI]
33. 33 FGF Binding and FGF Receptor Activation by Synthetic Heparan-Derived Di- and Trisaccharides [DOI]
34. 34 The Fibroblast Growth Factor Receptor Is at the Site of Convergence between μ-Opioid Receptor and Growth Factor Signaling Pathways in Rat C6 Glioma Cells [DOI]
35. 35 Fibroblast growth factor inhibits interferon γ-STAT1 and interleukin 6-STAT3 signaling in chondrocytes [DOI]
36. 36 Fibroblast growth factor receptors as therapeutic targets in clear-cell renal cell carcinoma [DOI]
37. 37 Selective FGFR/FGF pathway inhibitors: inhibition strategies, clinical activities, resistance mutations, and future directions [DOI]
38. 38 Targeting fibroblast growth factor receptor pathway in breast cancer [DOI]
39. 39 Molecular pathways and targeted therapy in cholangiocarcinoma.
40. 40 Fibroblast growth factor receptor inhibitors: patent review (2015–2019) [DOI]
41. 41 Role of FGF Receptors and Their Pathways in Adrenocortical Tumors and Possible Therapeutic Implications [DOI]
42. 42 New Insights in the Interaction of FGF/FGFR and Steroid Receptor Signaling in Breast Cancer [DOI]
43. 43 Cross‐talk between FGF and other cytokine signalling pathways during endochondral bone development [DOI]
44. 44 FGFR-gerichtete Therapie von Kopf-Hals-Karzinomen [DOI]
45. 45 Signaling molecules that mediate the actions of FGF.
46. 46 Fibroblast Growth Factor Receptor Inhibitors [DOI]
47. 47 Current and Future Therapeutical Aspects of X-Linked Hypophosphatemia in Children With Special Attention to Klotho/Fibroblast Growth Factor 23 System [DOI]
48. 48 [FGF receptor and FGF signaling pathways].
49. 49 FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease [DOI]
50. 50 Genetic insights into the mechanisms of Fgf signaling [DOI]
51. 51 FGFR Inhibitors in Cholangiocarcinoma—A Novel Yet Primary Approach: Where Do We Stand Now and Where to Head Next in Targeting This Axis? [DOI]
52. 52 Biological and clinical implications of FGFR aberrations in paediatric and young adult cancers [DOI]
53. 53 The FGF/FGFR signalling mediated anti-cancer drug resistance and therapeutic intervention [DOI]

Cited by 0

No indexed citations yet.

Related research

• Assessment of Glycaemic Control among Diabetic Patients Attending Care at Bowen University Teaching Hospital, Ogbomoso — shares topic coverage
• Epidemiological Assessment and Challenges of the COVID-19 Pandemic in Nigeria — shares topic coverage
• An Appraisal of Introduced African Catfish Clarias gariepinus (Burchell 1822) in India: Invasion and Risks — shares topic coverage
• Public Health Risk of Abattoir Operation in Zango Abattoir Zaria, Kaduna State Nigeria — shares topic coverage
• Assessment of the Relationship between Cerebrospinal Meningitis and Climate Variables in Kaduna State, Nigeria — shares topic coverage